share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Marriott Tina
美股sec公告 ·  06/28 17:19
Moomoo AI 已提取核心訊息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Recursion Pharmaceuticals總裁兼首席運營官Tina Marriott於2024年6月27日出售了公司的6,000股A類普通股。交易價格爲每股7.215美元，總市值爲43,290美元。銷售後，Marriott在該公司的直接持股爲535,457股。該銷售是在公開市場上進行的，並與衍生證券行使同時進行，Marriott在同一天以1.06美元的價格收購了相等數量的股票。
Recursion Pharmaceuticals總裁兼首席運營官Tina Marriott於2024年6月27日出售了公司的6,000股A類普通股。交易價格爲每股7.215美元，總市值爲43,290美元。銷售後，Marriott在該公司的直接持股爲535,457股。該銷售是在公開市場上進行的，並與衍生證券行使同時進行，Marriott在同一天以1.06美元的價格收購了相等數量的股票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息